Top Story

Clinical Trial Data Network Social
Clinical Trial
Large language models tapped for speeding up clinical trial enrollment in U.S.
Meanwhile, the FDA envisions integrating more clinical trial activities into local healthcare facilities, roaming mobile research units, and through at-home lab testing kits.
Featured
Baby Infant Mom Closeup Social
Research and Development
Revvity broadens work in newborn testing for NHS England
Ovarian Cancer2 Social
Regulatory Approval
Roche gets CE Mark for ovarian cancer CDx test
Latest News
Covid Treatment Doctor Social
AMP reviews pitfalls of NGS testing for SARS-CoV-2
November 15, 2024
Diagnostic Analyzer Lab Pcr Social
FDA fall IVD roundtable avoids LDT questions
November 12, 2024
Body composition in patients treated with Ozempic
Sponsored
Body composition in patients treated with Ozempic
September 20, 2024
Artificial Intelligence Ai Hand Social
Digital pathology rollouts race for proof-of-concept at national level
October 29, 2024
Agreement Legal Settlement Social
Agreement
Labcorp completes lab asset acquisition, names new CFO
Collaboration
Proscia to offer Owkin's CRC test through platform
Regulatory Approval
Roche gets CE Mark for ovarian cancer CDx test
Collaboration
Vesalius, GSK announce strategic alliance on neurodegenerative disease treatments
Dna Sequencing Social
PCR
Precision for Medicine partners with Agena Bioscience to fill NGS testing gaps
Clinical Trial
Large language models tapped for speeding up clinical trial enrollment in U.S.
Regulatory Approval
Roche gets CE Mark for ovarian cancer CDx test
Gene expression
Lunit adds AstraZeneca for NSCLC biomarker screening AI
Nsclc Slides
Gene expression
Lunit adds AstraZeneca for NSCLC biomarker screening AI
Collaboration
Vesalius, GSK announce strategic alliance on neurodegenerative disease treatments
Liquid Biopsy
Biofidelity launches lung reagent for integrated tissue and liquid biopsy analysis
Emerging Technology
Brain tumor collaborative offers $500K for practice changing liquid biopsy studies
More from LabPulse.com
Precision for Medicine partners with Agena Bioscience to fill NGS testing gaps
By LabPulse.com staff writers
Partnership addresses insufficient sample quality in next-generation sequencing (NGS) testing.
November 20, 2024
Dna Sequencing Social
Labcorp completes lab asset acquisition, names new CFO
By LabPulse.com staff writers
Labcorp has completed its acquisition of the molecular testing site and other assets of an independent clinical laboratory in Birmingham, AL.
November 20, 2024
Agreement Legal Settlement Social
Proscia to offer Owkin's CRC test through platform
By LabPulse.com staff writers
Digital pathology firm Proscia and artificial intelligence biotech company Owkin will collaborate to make Owkin's colorectal cancer (CRC) diagnostic test available through Proscia's digital pathology software platform.
November 20, 2024
Digital Science Lab Social
Lunit adds AstraZeneca for NSCLC biomarker screening AI
By LabPulse.com staff writers
Companies to integrate Scope Genotype Predictor into pathology workflows to screen for actionable mutations in non-small cell lung cancer research.
November 18, 2024
Nsclc Slides
Vesalius, GSK announce strategic alliance on neurodegenerative disease treatments
By LabPulse.com staff writers
Biotech firm Vesalius Therapeutics announced a strategic collaboration with GSK aimed at the discovery and development of therapeutics for Parkinson's disease and another undisclosed neurodegenerative disease.
November 15, 2024
Parkinsons Neuron Social
Gilead announces impending layoffs, facility closure
By LabPulse.com staff writers
Gilead Sciences announced an impending layoff at its Bay Area headquarters, as well as its office in Seattle, and plans to close the Philadelphia facility of its subsidiary Kite Pharma.
November 18, 2024
Layoff Form Sign Social
Biofidelity launches lung reagent for integrated tissue and liquid biopsy analysis
By LabPulse.com staff writers
Biofidelity has launched its Aspyre Lung Reagents molecular diagnostic assay for identifying NSCLC biomarkers in both DNA and RNA.
November 14, 2024
Cancer Therapy Targeted Social
Brain tumor collaborative offers $500K for practice changing liquid biopsy studies
By LabPulse.com staff writers
The research should be practice-changing.
November 14, 2024
Lab Test Tube Dna Blood Social
Alveo Technologies to develop avian influenza A(H5) test with CDC
By LabPulse.com staff writers
Under the agreement with the CDC, Alveo Technologies will develop a rapid diagnostic to detect and differentiate between influenza A and B and influenza A/H5, also known as the avian influenza subtype, in humans.
November 14, 2024
Colorized transmission electron micrograph of avian influenza A H5N1 virus particles shown in yellow.
Flatiron to offer Tempus AI's testing through OncoEMR platform
By LabPulse.com staff writers
Flatiron Health will incorporate comprehensive genetic testing from precision medicine firm Tempus AI directly into its cloud-based electronic medical record (EMR) platform.
November 13, 2024
Computer Doctor Report Digital Social
23andMe to lay off 40% of employees, discontinue therapeutics division
By LabPulse.com staff writers
Genetic testing company 23andMe will lay off more than 200 employees -- 40% of its workforce -- and discontinue its therapeutics division.
November 13, 2024
Layoff Form Sign Social
Mainz Biomed, Thermo Fisher collaborate on CRC screening test
By LabPulse.com staff writers
Mainz Biomed and Thermo Fisher Scientific will jointly develop and potentially commercialize Mainz Biomed's next-generation colorectal cancer (CRC) screening test.
November 12, 2024
Colorectal Cancer Social